logo

NXGL

NexGel·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Ample Liquidity
Revenue Beats Expectation
EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About NXGL

Nexgel, Inc.

A company that develops and commercializes next-generation hydrogel products for wound care and medical applications

Healthcare Equipment and Supplies
01/13/2009
12/22/2021
NASDAQ Stock Exchange
19
12-31
Common stock
2150 Cabot Boulevard, West , Suite B , Langhorne, Pennsylvania 19047
--
NexGel, Inc., was incorporated in Delaware on January 13, 2009. They produce high water content, electron beam cross-linking, aqueous polymer hydrogels or gels for wound care, medical diagnosis, transdermal drug delivery and cosmetics. They focus on customizing gels using proprietary manufacturing techniques. They have historically acted as contract manufacturers, supplying gels to third parties and incorporating them into their own products. Their products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Earnings Call

Company Financials

EPS

NXGL has released its 2025 Q3 earnings. EPS was reported at -0.08, versus the expected -0.08, meeting expectations. The chart below visualizes how NXGL has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NXGL has released its 2025 Q3 earnings report, with revenue of 2.93M, reflecting a YoY change of -0.20%, and net profit of -647.00K, showing a YoY change of 14.19%. The Sankey diagram below clearly presents NXGL's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime